Previous studies have demonstrated the ability of conventional DWI and DTI to distinguish IDH-mutant gliomas from IDH wild-type gliomas (Xiong et al., 2016; Wu et al., 2018). This evidence concerns the gene IDH1 and central nervous system cancer.